528 related articles for article (PubMed ID: 28141856)
1. Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype.
Kong F; Saldarriaga OA; Spratt H; Osorio EY; Travi BL; Luxon BA; Melby PC
PLoS Pathog; 2017 Jan; 13(1):e1006165. PubMed ID: 28141856
[TBL] [Abstract][Full Text] [Related]
2. Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression.
Medina-Colorado AA; Osorio EY; Saldarriaga OA; Travi BL; Kong F; Spratt H; Soong L; Melby PC
PLoS One; 2017; 12(1):e0169496. PubMed ID: 28103263
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes.
Espitia CM; Saldarriaga OA; Travi BL; Osorio EY; Hernandez A; Band M; Patel MJ; Medina AA; Cappello M; Pekosz A; Melby PC
BMC Immunol; 2014 Nov; 15():38. PubMed ID: 25424735
[TBL] [Abstract][Full Text] [Related]
4. Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression.
Osorio EY; Zhao W; Espitia C; Saldarriaga O; Hawel L; Byus CV; Travi BL; Melby PC
PLoS Pathog; 2012 Jan; 8(1):e1002417. PubMed ID: 22275864
[TBL] [Abstract][Full Text] [Related]
5. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response.
Melby PC; Chandrasekar B; Zhao W; Coe JE
J Immunol; 2001 Feb; 166(3):1912-20. PubMed ID: 11160239
[TBL] [Abstract][Full Text] [Related]
6. Growth factor and Th2 cytokine signaling pathways converge at STAT6 to promote arginase expression in progressive experimental visceral leishmaniasis.
Osorio EY; Travi BL; da Cruz AM; Saldarriaga OA; Medina AA; Melby PC
PLoS Pathog; 2014 Jun; 10(6):e1004165. PubMed ID: 24967908
[TBL] [Abstract][Full Text] [Related]
7. Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis.
Melby PC; Tryon VV; Chandrasekar B; Freeman GL
Infect Immun; 1998 May; 66(5):2135-42. PubMed ID: 9573100
[TBL] [Abstract][Full Text] [Related]
8. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
[TBL] [Abstract][Full Text] [Related]
9. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
[TBL] [Abstract][Full Text] [Related]
10. Infection pattern and immune response in the spleen and liver of BALB/c mice intracardially infected with Leishmania donovani amastigotes.
Mukherjee P; Ghosh AK; Ghose AC
Immunol Lett; 2003 Apr; 86(2):131-8. PubMed ID: 12644314
[TBL] [Abstract][Full Text] [Related]
11. In-situ proliferation contributes to the accumulation of myeloid cells in the spleen during progressive experimental visceral leishmaniasis.
Osorio EY; Medina-Colorado AA; Travi BL; Melby PC
PLoS One; 2020; 15(11):e0242337. PubMed ID: 33180876
[TBL] [Abstract][Full Text] [Related]
12. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
13. Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen.
Basu A; Chakrabarti G; Saha A; Bandyopadhyay S
Immunology; 2000 Feb; 99(2):305-13. PubMed ID: 10692051
[TBL] [Abstract][Full Text] [Related]
14. Imaging visceral leishmaniasis in real time with golden hamster model: Monitoring the parasite burden and hamster transcripts to further characterize the immunological responses of the host.
Rouault E; Lecoeur H; Meriem AB; Minoprio P; Goyard S; Lang T
Parasitol Int; 2017 Feb; 66(1):933-939. PubMed ID: 27794505
[TBL] [Abstract][Full Text] [Related]
15. Status of IL-4 and IL-10 driven markers in experimental models of Visceral Leishmaniasis.
Moulik S; Karmakar J; Joshi S; Dube A; Mandal C; Chatterjee M
Parasite Immunol; 2021 Jan; 43(1):e12783. PubMed ID: 32734677
[TBL] [Abstract][Full Text] [Related]
16. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
Paul J; Karmakar S; De T
Eur J Immunol; 2012 Aug; 42(8):2087-99. PubMed ID: 22622993
[TBL] [Abstract][Full Text] [Related]
17. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
Choudhury R; Das P; De T; Chakraborti T
Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
[TBL] [Abstract][Full Text] [Related]
18. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
[TBL] [Abstract][Full Text] [Related]
19. Oceanimonas sp. BPMS22-derived protein protease inhibitor induces anti-leishmanial immune responses through macrophage M2 to M1 repolarization.
Jayaraman A; Srinivasan S; Kar A; Harish BS; Charan Raja MR; Uppuluri KB; Kar Mahapatra S
Int Immunopharmacol; 2022 Nov; 112():109281. PubMed ID: 36183681
[TBL] [Abstract][Full Text] [Related]
20. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis.
Nylén S; Maurya R; Eidsmo L; Manandhar KD; Sundar S; Sacks D
J Exp Med; 2007 Apr; 204(4):805-17. PubMed ID: 17389235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
